Satyadeva Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Medak, Telangana, India, established in 2000.
2000 Medak, Telangana, India Active
Last Updated:
Access Report
About Satyadeva Pharmaceuticals Private Limited

Satyadeva Pharmaceuticals Private Limited, a active private limited company, was established on 11 August 2000 in Medak, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG2000PTC035107. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.00 Cr.

It upholds a compliant status. Employing 149 professional, Its leadership includes Swathi Nandamuri (Director), Eswara Narayana Kosaraju (Managing Director), Srinivasa Rao Tubati (Whole-Time Director). Past directors included Srinivasa Rao Tubati, Nageswara Rao Pinneti, Buragadda Srinivasa Rao. It holds ₹13.09 Cr open charges and ₹39.65 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot Nos. 19 To 28, Phase Ii, Ida, Pashamylaram,, Medak, Telangana, 502307.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2000PTC035107

  • Registration Number

    035107

  • Incorporation Date

    11 August 2000

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 25 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 13.09 Cr
  • Satisfied Charges ₹ 39.65 Cr
  • Revenue Growth **** -0.86%
  • Profit Growth **** -49.81%
  • Ebitda **** -321.59%
  • Net Worth 2.27%
  • Total Assets **** 11.87%
Company report

Satyadeva Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Satyadeva Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Satyadeva Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Swathi Nandamuri Director 01 Apr 2019 Current
Eswara Narayana Kosaraju Managing Director 11 Aug 2000 Current
Srinivasa Rao Tubati Whole-Time Director 21 Jul 2005 Current
Venkata Prasad Averineni Whole-Time Director 21 Jul 2005 Current
Hari Krishna Kosaraju Director 01 Apr 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 31 Dec 2020 Past
Pramod Abcsdd Director 11 Sep 2012 Past
Pramod Abcsdd Director 11 Sep 2012 Past
Pramod Abcsdd Whole-Time Director 31 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Satyadeva Pharmaceuticals.

Satyadeva Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.86% decrease. The company also saw a substantial fall in profitability, with a 49.81% decrease in profit. The company's net worth moved up by a moderate rise of 2.27%.

Satyadeva Pharmaceuticals revenue growth over time
Satyadeva Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -0.86%
*******
*******
*******
*******
Revenue from Operations
*******
 -14.95%
*******
*******
*******
*******
Total Assets
*******
 11.87%
*******
*******
*******
*******
Profit or Loss
*******
 -49.81%
*******
*******
*******
*******
Net Worth
*******
 2.27%
*******
*******
*******
*******
EBITDA
*******
 -321.59%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Satyadeva Pharmaceuticals?

In 2023, Satyadeva Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹130,900,000.00

Satisfied Charges

₹396,500,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 7.10 Cr
  • Others : 5.00 Cr
  • Hdfc Bank Limited : 0.99 Cr
Latest Charge Details
Date Lender Amount Status
13 Mar 2025 Hdfc Bank Limited ₹9.90 M Open
07 Nov 2024 Others ₹5.00 Cr Open
23 Jun 2016 Axis Bank Limited ₹7.10 Cr Open
30 Oct 2017 Hdfc Bank Limited ₹18.00 Cr Satisfied
22 Aug 2016 Axis Bank Limited ₹16.60 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Satyadeva Pharmaceuticals?

Satyadeva Pharmaceuticals has a workforce of 149 employees as of Sep 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Satyadeva Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyadeva Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Satyadeva Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Satyadeva Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Satyadeva Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.99 Cr with Charge ID 101066338 was registered on 13 Mar 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others of Rs. 5.00 Cr registered on 07 Nov 2024 with Charge ID 101023543 was modified on 12 Mar 2025. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101023543 was registered on 07 Nov 2024. was documented.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 7.10 Cr registered on 23 Jun 2016 with Charge ID 100038814 was modified on 22 Dec 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Satyadeva Pharmaceuticals Private Limited?

The CIN of Satyadeva Pharmaceuticals Private Limited is U24239TG2000PTC035107.

Where is Satyadeva Pharmaceuticals Private Limited headquartered?

Satyadeva Pharmaceuticals Private Limited is headquartered at Plot Nos. 19 To 28, Phase Ii, Ida, Pashamylaram,, Medak, Telangana, 502307.

When was Satyadeva Pharmaceuticals Private Limited incorporated?

Satyadeva Pharmaceuticals Private Limited was incorporated on 11 August 2000.

Who are the current directors of Satyadeva Pharmaceuticals Private Limited?

The current directors of Satyadeva Pharmaceuticals Private Limited are

What is the primary industry of Satyadeva Pharmaceuticals Private Limited?

The primary industry of Satyadeva Pharmaceuticals Private Limited is Manufacturing.

Is Satyadeva Pharmaceuticals Private Limited a listed company?

Satyadeva Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Satyadeva Pharmaceuticals Private Limited?

The authorized capital of Satyadeva Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Satyadeva Pharmaceuticals Private Limited?

The compliance status of Satyadeva Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available